PMGC Holdings Inc. (ELAB) stock
Close on Nov 12, 2026Market cap $12.87MP/E –Yield –
PMGC Holdings Inc. reported revenue of $2.58M for the twelve months to Jun 30, 2026. Free cash flow was -$6.38M. At the latest close the market valued the company at $12.87M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $12.87M
- P/E ratio
- –
- Price to sales
- 4.99
- Price to book
- 0.77
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $2.58M
- Net income
- -$13.49M
- Free cash flow
- -$6.38M
- Book value per share
- $3.43
- Diluted shares
- 5M
Trading
- Previous close
- $1.58
- Open
- $1.51
- Day's range
- $1.51 – $1.64
- Volume
- 35,613
- Average volume (20 days)
- 707,178
- Beta (5 years)
- 1.69
- 52-week range
- $1.41 – $1432.77
- RSI (14 days)
- 18.9
- Volatility (1 year)
- 239.8%
- Relative volume
- 0.14×
- WACC
- 13.3%
Market cap history
Month-end market cap since 2023, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | ELAB | S&P 500 | Difference | ELAB per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -47.9% | -2.7% | −45.2 pts | ||
| 3 months | -82.3% | -1.7% | −80.6 pts | ||
| Year to date | -99.6% | +11.9% | −111.4 pts | ||
| 1 year | -99.9% | +12.0% | −111.9 pts |
Five years at a glance
Fiscal years 2021 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Net income
EPS, diluted
Free cash flow
Press releases
Releases PMGC filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Update
- Update
- Update
- Update
About PMGC
Pharmaceutical Preparations
PMGC Holdings Inc. is a diversified holding company that manages and operates a portfolio of four wholly owned operating subsidiaries. Its subsidiary Northstrive Biosciences develops biopharmaceutical and aesthetic medicine candidates, focusing on engineered probiotic therapies designed to preserve muscle mass during weight loss treatment. Subsidiary Pacific Sun Packaging designs and supplies custom-engineered protective packaging solutions, including trays and carriers for delicate computer processors, memory modules, storage drives, and optical transceivers. Subsidiary AGA Precision Systems operates as a specialized computer numerical control machine shop providing high-tolerance milling, turning, and mold manufacturing for complex metals such as titanium and Inconel. PMGC Capital operates as an investment subsidiary engaged in multi-strategy investing and lending.
Company profile, executives and historyPMGC stock: common questions
What is PMGC's stock price?
ELAB closed at $1.59 on Nov 12, 2026, up 0.63% on the day. Over the past 52 weeks it traded between $1.41 and $1432.77.
What is PMGC's market cap?
PMGC was worth $12.87M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
How much revenue does PMGC make?
PMGC reported revenue of $2.58M for the twelve months to Jun 30, 2026.
Does PMGC pay a dividend?
No. PMGC has not paid a cash dividend over the last twelve months.
How has ELAB stock performed over the past year?
Including dividends, ELAB returned -99.9% over the past year, against +12.0% for the S&P 500.
How many ELAB shares are sold short?
0M shares were sold short at the latest FINRA report, 0.51% of the float, or 2.6 days of average trading volume.
Who are PMGC's competitors?
Companies most similar to PMGC by business, industry and size include PMHS, PTCHF, BIOE, CPHI, ORMP.
See a number that looks wrong?